PI3K-AKT-mTOR Signaling: Overexpression of CPA4 in pancreatic cancer cells has been shown to activate the PI3K-AKT-mTOR pathway, promoting EMT, enhancing cell proliferation, and increasing drug resistance. Here, CPA4 is linked to familial pancreatic carcinoma.